- R&D
Onward awarded $1.1M grant from the Christopher & Dana Reeve Foundation to advance BCI research
Onward Medical revealed that it has received a major grant from the Christopher & Dana Reeve Foundation to continue with BCI research. This $1.1M...Germany to Provide 100,000 Mpox Vaccine Doses to Combat Outbreak in Africa
Germany has provided 100,000 doses of the Mpox vaccine from its armed forces to help combat the ongoing outbreak in Africa, a government spokesperson...Covid Symptoms Prevented by New Drug Used on Mice, No Risk of Resistance
Research findings from new studies show that organ damage resulting from Covid-19 can be averted by an antioxidant enzyme that shields a cell’s mitochondria....Novo’s Wegovy leads to women losing more weight than men
In a study conducted on women and men with heart failure compared to a placebo, and presented at the American Diabetes Association’s 2024 research...
- Clinical
Viridian Drug Successfully Meets Study Objectives as Treatment for Thyroid Eye Disease
Viridian announced that veligrotug, its potential thyroid eye disease (TED) drug, recorded impressive results in managing TED during a late-phase trial. The increase...Relay Wins Early on Breast Cancer, Arranges Crucial Trial Against Truqap from AstraZeneca
Relay Therapeutics released interim Phase I/II data showing that RLY-2608, its investigational PI3Kα inhibitor, demonstrated “clinically meaningful” progression-free survival (PFS) in patients with specific...Tern’s oral GLP-1 achieves 5% weight reduction within one month at the highest dose
Terns Pharmaceuticals’ decision to move away from the liver disease field may turn out to be beneficial since early phase 1 data suggests that...GSK’s Asthma Drug Meets Primary Endpoint in Phase 3 Trial
After successfully completing two trials, SWIFT-1 and SWIFT-2, for its long-acting asthma drug depemokimab, GSK has now shared results for its Phase 3 trial....
- Manufacturing
Novo Nordisk Planning Huge $4.1B Plant in NC For Ozempic Production
It seems like GLP-1 giants Novo Nordisk and Eli Lilly are locked in a fierce battle as they work towards scaling production to meet...French Company Orano Med Opens New Radiation Production Facility Near Indianapolis
In a nuclear medicine surge, industry leader Orano Med has selected the U.S. as a production site for further radiopharma development. Orano Med, which...Gerresheimer Increases the Capabilities of Medical Systems in the USA
Gerresheimer, the maker of innovative systems and solutions and a partner to the pharma, biotech, and cosmetics industries, is increasing the production capacity of...Novo Nordisk invests $560 million to increase Chinese medicine production
Novo Nordisk, a prominent player in the pharmaceutical industry, is commemorating three decades of operations in China, coinciding with the potential approval of its...
- Commercial
Gilead and AI Drug Discovery Company Genesis Sign $35 Million Partnership
Genesis Therapeutics’ AI drug discovery platform, GEMS, has gained popularity and now attracted the attention of Gilead Sciences with a $35M partnership. In a major...Brightflow SAS Nabs $18M For Heart Failure Solution
Brightflow SAS, a privately owned company at the forefront in the area of long-term percutaneous mechanical circulatory assistance for the treatment of patients in...Allist Secures Leading Role in China’s KRAS Inhibitor Market with $21M Jacobio Deal
Shanghai Allist Pharmaceuticals has significantly bolstered its position in China's burgeoning KRAS inhibitor market through a strategic agreement with Jacobio Pharma. This deal, valued...
- Technology
Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient
Neuralink, founded by Elon Musk, revealed that it has placed its device in the second human trial subject. The therapeutic application of the technology...AI Firm Formation Bags $372 Series D Funding
In 2024, megarounds have been extremely uncommon. Nonetheless, Formation Bio was able to secure a remarkable series D funding round of $372 million as...Health-Tech Startup Evidation Opens Up Its Symptom-Logging App To Track Migraine Discomfort
Mohsin Riaz - 0California health technology firm Evidation is making its app for logging symptoms more open to track how migraine symptoms. MigraineSmart, which is a part...Musk’s Neuralink Aiming to Enroll Three Patients in Brain Implant Research
According to the information on the clinical trials database maintained by the U.S. government, Neuralink, the brain-chip firm owned by Elon Musk, intends to...
- Regulatory
Illumina Gets Favorable Decision Regarding Grail Acquisition
In a decision expected to limit Brussels' merger authority, American gene sequencing firm Illumina prevailed in court against the European Union's inquiry into its...Emergent Bio’s Smallpox Vaccine Gains FDA Approval for Mpox
Emergent BioSolutions' smallpox vaccine has received expanded approval from the U.S. Food and Drug Administration (FDA) for use in individuals at high risk of...Bavarian Nordic Receives Mpox Vaccine Green Light From Singapore
Bavarian Nordic announced today that its vaccine, JYNNEOS, has been licensed by Singapore's Health Sciences Authority (HSA) for the prevention of smallpox and mpox...Ascendis Receives a Grudging FDA Approval for Yorvipath, a Hormone Replacement Treatment
Ascendis Pharma should be in a good position to launch its hormone replacement therapy for hypoparathyroidism in the U.S. market, as it received FDA...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
- R&D
Onward awarded $1.1M grant from the Christopher & Dana Reeve Foundation to advance BCI research
Onward Medical revealed that it has received a major grant from the Christopher & Dana Reeve Foundation to continue with BCI research. This $1.1M...Germany to Provide 100,000 Mpox Vaccine Doses to Combat Outbreak in Africa
Germany has provided 100,000 doses of the Mpox vaccine from its armed forces to help combat the ongoing outbreak in Africa, a government spokesperson...Covid Symptoms Prevented by New Drug Used on Mice, No Risk of Resistance
Research findings from new studies show that organ damage resulting from Covid-19 can be averted by an antioxidant enzyme that shields a cell’s mitochondria....Novo’s Wegovy leads to women losing more weight than men
In a study conducted on women and men with heart failure compared to a placebo, and presented at the American Diabetes Association’s 2024 research...
- Clinical
Viridian Drug Successfully Meets Study Objectives as Treatment for Thyroid Eye Disease
Viridian announced that veligrotug, its potential thyroid eye disease (TED) drug, recorded impressive results in managing TED during a late-phase trial. The increase...Relay Wins Early on Breast Cancer, Arranges Crucial Trial Against Truqap from AstraZeneca
Relay Therapeutics released interim Phase I/II data showing that RLY-2608, its investigational PI3Kα inhibitor, demonstrated “clinically meaningful” progression-free survival (PFS) in patients with specific...Tern’s oral GLP-1 achieves 5% weight reduction within one month at the highest dose
Terns Pharmaceuticals’ decision to move away from the liver disease field may turn out to be beneficial since early phase 1 data suggests that...GSK’s Asthma Drug Meets Primary Endpoint in Phase 3 Trial
After successfully completing two trials, SWIFT-1 and SWIFT-2, for its long-acting asthma drug depemokimab, GSK has now shared results for its Phase 3 trial....
- Manufacturing
Novo Nordisk Planning Huge $4.1B Plant in NC For Ozempic Production
It seems like GLP-1 giants Novo Nordisk and Eli Lilly are locked in a fierce battle as they work towards scaling production to meet...French Company Orano Med Opens New Radiation Production Facility Near Indianapolis
In a nuclear medicine surge, industry leader Orano Med has selected the U.S. as a production site for further radiopharma development. Orano Med, which...Gerresheimer Increases the Capabilities of Medical Systems in the USA
Gerresheimer, the maker of innovative systems and solutions and a partner to the pharma, biotech, and cosmetics industries, is increasing the production capacity of...Novo Nordisk invests $560 million to increase Chinese medicine production
Novo Nordisk, a prominent player in the pharmaceutical industry, is commemorating three decades of operations in China, coinciding with the potential approval of its...
- Commercial
Gilead and AI Drug Discovery Company Genesis Sign $35 Million Partnership
Genesis Therapeutics’ AI drug discovery platform, GEMS, has gained popularity and now attracted the attention of Gilead Sciences with a $35M partnership. In a major...Brightflow SAS Nabs $18M For Heart Failure Solution
Brightflow SAS, a privately owned company at the forefront in the area of long-term percutaneous mechanical circulatory assistance for the treatment of patients in...Allist Secures Leading Role in China’s KRAS Inhibitor Market with $21M Jacobio Deal
Shanghai Allist Pharmaceuticals has significantly bolstered its position in China's burgeoning KRAS inhibitor market through a strategic agreement with Jacobio Pharma. This deal, valued...
- Technology
Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient
Neuralink, founded by Elon Musk, revealed that it has placed its device in the second human trial subject. The therapeutic application of the technology...AI Firm Formation Bags $372 Series D Funding
In 2024, megarounds have been extremely uncommon. Nonetheless, Formation Bio was able to secure a remarkable series D funding round of $372 million as...Health-Tech Startup Evidation Opens Up Its Symptom-Logging App To Track Migraine Discomfort
Mohsin Riaz - 0California health technology firm Evidation is making its app for logging symptoms more open to track how migraine symptoms. MigraineSmart, which is a part...Musk’s Neuralink Aiming to Enroll Three Patients in Brain Implant Research
According to the information on the clinical trials database maintained by the U.S. government, Neuralink, the brain-chip firm owned by Elon Musk, intends to...
- Regulatory
Illumina Gets Favorable Decision Regarding Grail Acquisition
In a decision expected to limit Brussels' merger authority, American gene sequencing firm Illumina prevailed in court against the European Union's inquiry into its...Emergent Bio’s Smallpox Vaccine Gains FDA Approval for Mpox
Emergent BioSolutions' smallpox vaccine has received expanded approval from the U.S. Food and Drug Administration (FDA) for use in individuals at high risk of...Bavarian Nordic Receives Mpox Vaccine Green Light From Singapore
Bavarian Nordic announced today that its vaccine, JYNNEOS, has been licensed by Singapore's Health Sciences Authority (HSA) for the prevention of smallpox and mpox...Ascendis Receives a Grudging FDA Approval for Yorvipath, a Hormone Replacement Treatment
Ascendis Pharma should be in a good position to launch its hormone replacement therapy for hypoparathyroidism in the U.S. market, as it received FDA...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
Editor Picks
Soterios Achieves Phase 2 Success for Alopecia Cream as an Alternative to JAK Inhibitors
Soterios Pharma plans to proceed to phase 3 trials after its 1% Alopecia areata...
Karuna Therapeutics Phase 1b Trial Results Reinforce Cardiovascular Safety of Schizophrenia Treatment KarXT
The Phase 1b unrestricted-label, eight-week residential trial meant to assess the influence...
Unlearn Secures $50 Million in latest funding round
Unlearn, a developer specializing in digital replicas, recently disclosed its attainment of...
Must Read
Gilead and AI Drug Discovery Company Genesis Sign $35 Million Partnership
Genesis Therapeutics’ AI drug discovery platform, GEMS, has gained popularity and now attracted the...
Brightflow SAS Nabs $18M For Heart Failure Solution
Brightflow SAS, a privately owned company at the forefront in the area of long-term...
Viridian Drug Successfully Meets Study Objectives as Treatment for Thyroid Eye Disease
Viridian announced that veligrotug, its potential thyroid eye disease (TED) drug, recorded impressive...
About Us
Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.
Contact us: reachout(at)lifescivoice.com